Hmmm I thought its cash position was pretty solid? Fund Manager buying in and VIP and expenses are largely covered now and operating out of OPEX? or maybe another investor or an acquisition? Bit of a surprise to be honest.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025